
Kineta Announces Reverse Merger with NASDAQ-listed Yumanity Therapeutics (YMTX)
Yumanity Therapeutics announces definitive agreements for two strategic transactions Yumanity Therapeutics, Inc. to sell its clinical-stage product candidate YTX-7739 as well as its unpartnered disco ...